Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
145.3 USD | +0.78% | +2.21% | -4.38% |
24/04 | Raymond James Adjusts Price Target on D.R. Horton to $170 From $160 | MT |
19/04 | Consumer Stocks Slide on Rate Concerns -- Consumer Roundup | DJ |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- With a P/E ratio at 10.23 for the current year and 9.35 for next year, earnings multiples are highly attractive compared with competitors.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The company is not the most generous with respect to shareholders' compensation.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Homebuilding
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-4.38% | 47.86B | C+ | ||
+10.25% | 23.94B | C- | ||
+1.83% | 17.68B | B+ | ||
+13.06% | 14.58B | B+ | ||
+16.96% | 12.52B | C+ | ||
+0.30% | 6.2B | B | ||
+12.71% | 6.16B | A- | ||
+7.89% | 6.11B | B | ||
+9.62% | 5.96B | A- | ||
-8.67% | 5.92B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- DHI Stock
- Ratings DR Horton